デジタル定量吸入器の市場規模、シェア、動向分析レポート：製品別、適応症別、タイプ別、地域別、セグメント別予測、2023年～2030年

デジタル定量吸入器市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のデジタル定量吸入器市場規模は、2023年から2030年にかけて19.4%のCAGRを記録し、2030年までに533億2,000万米ドルに達すると予測されています。

この市場の有利な成長の主な要因には、継続的に増加する高齢者人口と慢性呼吸器疾患の急増が含まれます。

中国、インド、ブラジル、フィリピンなどの新興国における影響力のある経済発展の結果、一人当たりの所得が増加しており、これが技術的に進んだ呼吸器デバイスの需要に影響を与えると予想されています。さらに、これらの技術を活用した呼吸器デバイスは、患者の服薬コンプライアンスや用量トラッキングを改善し、医療データのリアルタイム追跡を可能にする患者と医療従事者の接続を強化するために、小児および高齢者の間で非常に求められています。これらは影響力の大きいレンダリング要因として機能し、今後9年間の市場の成長を大きく推進します。

対象人口の満たされていないニーズに対応するため、ベンダーは生産ユニットを拡大し、さらに、長期的な成長と収益性を確保するために、アジア太平洋地域やアンメットニーズのような慢性肺疾患や喘息の有病率が上昇しているニッチ地域をターゲットにしています。したがって、前述のような事業拡大動向は、予測期間中にデジタル定量吸入器の使用率を押し上げると予想されます。

さらに、米国FDAが進めるFixed Dose Combination（FDC）の導入、ジェネリック医薬品の急速な普及、デジタルヘルスプラットフォームに対する需要の高まりなど、有利な政府のイニシアチブは、これらのデジタル吸入器の急速な取り込みに影響を与える重要な決定要因であることが確認されており、これは今後数年間も続くと予想されます。

慢性睡眠時無呼吸症候群、喘息、COPDなどの様々な慢性呼吸器疾患の有病率の増加に伴う、世界の老年人口の急増は、医療システムに悪影響を与えます。これは、革新的な呼吸器デバイスへの需要をさらにエスカレートさせ、予測期間中のデジタル定量吸入器市場の成長を促進します。

デジタル定量吸入器市場レポートハイライト

• 2015年、定量吸入器（MDI）セグメントは5億6,390万米ドルの最大収益を占めました。
• しかし、ドライパウダー吸入器（DPI）セグメントは、MDIの推進剤として使用されるクロロフルオロカーボンの悪影響に関する意識の高まりにより、予測期間中にCAGR 16.9％で最も急成長するカテゴリーとして浮上すると予想されます。さらに、MDIによる薬剤刺激の蔓延と、MDIよりもDPIを使用する利点に関する意識の高まりが、予測期間中にDPIの使用率をさらに押し上げると予想される主要因です。
• 2015年には、ブランド医薬品の呼吸器デバイスカテゴリーが7億4,760万米ドルの最大市場シェアを占めました。
• 北米は2015年に38.64%以上の最大シェアを占めました。この大きなシェアは、Johnson &Johnson、Cohera Medical, Inc、Teleflex Medical, Inc、Covidien Plcなど、この地域に複数の医療機器プレーヤーが存在することに起因しています。この地域には6,000社を超える医療機器メーカーが存在し、その大半は中小企業です。さらに、高齢者人口の拡大や、喘息やCOPDなどの慢性呼吸器疾患の有病率の急増は、予測期間中にデジタル定量吸入器市場を積極的に強化すると予想される数少ない要因などです。
• アジア太平洋（APAC）地域は、予測期間中にCAGR 17.2％と有利なペースで成長すると予測されています。医療支出の急増と、中国やインドなどのAPAC諸国における米国FDA製造拠点の増加が、デジタル定量吸入器の市場浸透に大きな影響を与えると予想されます。
• さらに、呼吸器デバイスに採用されている様々な革新的技術に関する認知度の高まり、ジェネリック医薬品の使用をさらに奨励する現在進行中の有利な政府イニシアティブ、医療機器の電子部品製造に対する様々な補助金、およびこの地域からの医療デバイス輸出を可能にするいくつかの税制上の優遇措置は、予測期間中の市場成長を強力に強化すると予想されています。
• 市場をリードする企業には、Glenmark Pharmaceuticals Ltd.、Novartis AG、Propeller Health、AstraZeneca Plc、Philips Respironics、Opko Health, Inc.、Teva Pharmaceuticals Industries Ltd.などがあります。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
• 調査手法
• 情報調達
• 情報またはデータ分析
• 市場の形成と検証
• モデル詳細
• 二次情報のリスト
• 一次情報のリスト
• 目的

第2章 エグゼクティブサマリー

第3章 デジタル定量吸入器市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• デジタル定量吸入器市場分析ツール
  • 業界分析- ポーター
  • PESTEL分析

第4章 デジタル定量吸入器：製品の推定・動向分析

• デジタル定量吸入器市場：重要なポイント
• デジタル定量吸入器市場：動向と市場シェア分析、2022年および2030年
• 定量吸入器（MDI）
• ドライパウダー吸入器（DPI）

第5章 デジタル定量吸入器市場：タイプの推定・動向分析

• デジタル定量吸入器市場：重要なポイント
• デジタル定量吸入器市場：動向と市場シェア分析、2022年および2030年
• ブランド医薬品
• ジェネリック医薬品

第6章 デジタル定量吸入器市場：適応症の推定・動向分析

• デジタル定量吸入器市場：重要なポイント
• デジタル定量吸入器市場：動向と市場シェア分析、2022年および2030年
• 喘息
• 慢性閉塞性肺疾患（COPD）
• その他

第7章 デジタル定量吸入器市場：地域の推定・動向分析

• 地域の展望
• 地域別のデジタル定量吸入器市場：主要なマーケットプレース要点
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • 3M Company
  • AstraZeneca Plc
  • Glenmark Pharmaceuticals Ltd.
  • Novartis AG
  • Propeller Health
  • Sensirion AG Switzerland
  • Opko Health, Inc.
  • Teva Pharmaceuticals Industries Ltd
  • BEXIMCO Pharmaceuticals
  • GlaxoSmithKline Plc
  • Mundipharma Deutschland GmbH & Co. KG

List of Tables

• Table 1 List of abbreviation
• Table 2 North America digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 3 North America digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 4 North America digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 5 North America digital dose inhaler market, by region, 2018 - 2030 (USD Million)
• Table 6 U.S. digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 8 U.S. digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 9 Canada digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 11 Canada digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 12 Europe digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 13 Europe digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 14 Europe digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 15 Europe digital dose inhaler market, by region, 2018 - 2030 (USD Million)
• Table 16 Germany digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 17 Germany digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 18 Germany digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 19 UK digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 20 UK digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 21 UK digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 22 France digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 23 France digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 24 France digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 25 Italy digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 26 Italy digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 27 Italy digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 28 Spain digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 29 Spain digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 30 Spain digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 31 Sweden digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 32 Sweden digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 33 Sweden digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 34 Norway digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 35 Norway digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 36 Norway digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 37 Denmark digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 38 Denmark digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 39 Denmark digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific digital dose inhaler market, by region, 2018 - 2030 (USD Million)
• Table 44 China digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 45 China digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 46 China digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 47 Japan digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 48 Japan digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 49 Japan digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 50 India digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 51 India digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 52 India digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 53 Thailand digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 54 Thailand digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 55 Thailand digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 56 South Korea digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 57 South Korea digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 58 South Korea digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 59 Latin America digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 60 Latin America digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 61 Latin America digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 62 Latin America digital dose inhaler market, by region, 2018 - 2030 (USD Million)
• Table 63 Brazil digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 64 Brazil digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 65 Brazil digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 66 Mexico digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 67 Mexico digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 68 Mexico digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 69 Argentina digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 70 Argentina digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 71 Argentina digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 72 Middle East and Africa digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 73 Middle East and Africa digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 74 Middle East and Africa digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa digital dose inhaler market, by region, 2018 - 2030 (USD Million)
• Table 76 South Africa digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 77 South Africa digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 78 South Africa digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 79 UAE digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 80 UAE digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 81 UAE digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
• Table 82 Kuwait digital dose inhaler market, by product, 2018 - 2030 (USD Million)
• Table 83 Kuwait digital dose inhaler market, by type, 2018 - 2030 (USD Million)
• Table 84 Kuwait digital dose inhaler market, by indication, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Digital dose inhaler: Market outlook
• Fig. 9 Digital dose inhaler competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Digital dose inhaler market driver impact
• Fig. 15 Digital dose inhaler market restraint impact
• Fig. 16 Digital dose inhaler market strategic initiatives analysis
• Fig. 17 Digital dose inhaler market: Product movement analysis
• Fig. 18 Digital dose inhaler market: Product outlook and key takeaways
• Fig. 19 Metered Dose Inhaler (MDI) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Dry Powder Inhaler (DPI) market estimates and forecasts, (USD million), 2018 - 2030
• Fig. 21 Digital dose inhaler market: Type movement analysis
• Fig. 22 Digital dose inhaler market: Type outlook and key takeaways
• Fig. 23 Branded medication market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Generic medication market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Digital dose inhaler market: Indication movement analysis
• Fig. 26 Digital dose inhaler market: Indication outlook and key takeaways
• Fig. 27 Asthma market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Other market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Global digital dose inhaler market: Regional movement analysis
• Fig. 31 Global digital dose inhaler market: Regional outlook and key takeaways
• Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Digital Dose Inhaler Market Growth & Trends

The global digital dose inhaler market size is expected to reach USD 53.32 billion by 2030, registering a CAGR of 19.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors contributing to the lucrative growth of this market include the continually increasing elderly population and the surging prevalence of chronic respiratory diseases.

As a result of impactful economic developments in the fast emerging countries, such as China, India, Brazil, Philippines, and others, there has been growth in the per capita income, which is thus expected to influence the demand for the technologically advanced respiratory devices. Moreover, these technology-enabled respiratory devices are greatly sought after among the pediatric and the geriatric population so as to improve the patient medication compliance, dose tracking, and to enhance patient-healthcare practitioner connectivity that would enable real-time tracking of healthcare data; these serve as high impact rendering factors, significantly driving the market growth in the next nine years.

In order to cater to the unmet needs of the target population, the vendors are expanding their production units and in addition, targeting the niche areas where the prevalence of chronic lung diseases and asthma are on the rise, such as Asia Pacific and MEA regions, to ensure long-term growth and profitability. Therefore, the aforementioned, business expansion trends are expected to boost the usage rates of the digital dose inhalers over the forecast period.

Additionally, favorable government initiatives, such as the introduction of Fixed Dose Combination (FDC), advanced by the U.S. FDA, fast increasing adoption of generic drugs, and the growing demand for digital health platforms are the identified crucial determinants influencing the rapid uptake of these digital inhalers, which is expected to continue in the coming years.

Rapidly increasing geriatric population worldwide in conjunction with the growing prevalence of various chronic respiratory conditions, such as chronic sleep apnea, asthma, COPD, among others negatively impact healthcare system. This would further escalate the demand for innovative respiratory devices thereby encouraging the digital dose inhalers market growth during the forecast period.

Digital Dose Inhaler Market Report Highlights

• In 2015, the metered dose inhalers (MDIs) segment accounted for the maximum revenue of USD 563.9 million, mainly on account of the increased preference for MDIs.
• However, the dry powder inhalers (DPIs) segment is expected to emerge as the fastest growing category with a CAGR of 16.9% over the forecast period owing to the growing awareness regarding the adverse effects of chlorofluorocarbons employed as a propellant in the MDIs. Moreover, widespread incidences of drug irritation due to MDI and rising awareness regarding the benefits of using DPIs over MDIs are the leading factors expected to further drive the usage rates of DPIs over the forecast period.
• In 2015, the branded medication respiratory devices category accounted for the largest market share of USD 747.6 million attributable to the steadily growing need for advanced respiratory drugs and the awareness related to the benefits of combination medication gaining prominence.
• North America held the maximum share of over 38.64% in 2015. This large share is attributed to the presence of several medical device players in this region, such as Johnson & Johnson, Cohera Medical, Inc., Teleflex Medical, Inc., Covidien Plc, and others. There are over 6,000 medical device companies domiciled in this region, which majorly consists of small and medium sized enterprises (SMEs). Moreover, the soaring geriatric population count and the surging prevalence of chronic respiratory diseases, such as asthma and COPD, are few factors, among others, expected to positively reinforce the digital dose inhaler market over the forecast period.
• The Asia Pacific (APAC) region is anticipated to grow at a lucrative pace with a CAGR of 17.2% over the forecast period. The upsurge in the healthcare expenditure and the increasing number of U.S. FDA manufacturing sites in APAC countries, such as in China and India, are expected tosignificantly impact the market penetration of the digital dose inhalers.
• Furthermore, the growing awareness regarding the various innovative technologies employed in the respiratory devices, the ongoing favorable government initiatives that further encourage the use of generic drugs, various subsidies for electronic component manufacturing of medical devices, and several tax benefits that enable medical device exports from this region are anticipated to strongly reinforce the market growth over the forecast period.
• Some leading players of the market include Glenmark Pharmaceuticals Ltd., Novartis AG, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Inc., and Teva Pharmaceuticals Industries Ltd.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Type
  • 1.1.3. Indication
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Indication outlook
  • 2.2.3. Type outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Digital Dose Inhaler Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Digital Dose Inhaler Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Digital Dose Inhaler: Product Estimates & Trend Analysis

• 4.1. Digital Dose Inhaler Market: Key Takeaways
• 4.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Metered Dose Inhaler (MDI)
  • 4.3.1. Metered Dose Inhaler (MDI) market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Dry powder Inhaler (DPI)
  • 4.4.1. Dry Powder Inhaler (DPI) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Digital Dose Inhaler Market: Type Estimates & Trend Analysis

• 5.1. Digital Dose Inhaler Market: Key Takeaways
• 5.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Branded Medication
  • 5.3.1. Branded medication market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Generic Medication
  • 5.4.1. Generic medication market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Digital Dose Inhaler Market: Indication Estimates & Trend Analysis

• 6.1. Digital Dose Inhaler Market: Key Takeaways
• 6.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
• 6.3. Asthma
  • 6.3.1. Asthma market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Chronic Obstructive Pulmonary Disease (COPD)
  • 6.4.1. Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Digital Dose Inhaler Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Digital Dose Inhaler Market by Region: Key Marketplace Takeaway
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.3. France
    • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.6. Sweden
    • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.7. Norway
    • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. China
    • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.3. India
    • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. MEA
  • 7.7.1. Saudi Arabia
    • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. 3M Company
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. AstraZeneca Plc
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Glenmark Pharmaceuticals Ltd.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Novartis AG
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Propeller Health
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Sensirion AG Switzerland
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Opko Health, Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Teva Pharmaceuticals Industries Ltd
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. BEXIMCO Pharmaceuticals
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. GlaxoSmithKline Plc
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Mundipharma Deutschland GmbH & Co. KG
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives